Ignite Creation Date:
2024-05-06 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03549546
Status:
COMPLETED
Last Update Posted:
2019-07-26
First Post:
2018-05-25
Brief Title:
Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery
Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Organization:
Centre Hospitalier Universitaire de Saint Etienne
Study Overview
Official Title:
Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery
Status:
COMPLETED
Status Verified Date:
2018-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
POIR
Brief Summary:
Postoperative pneumonia is one of the most common complications after lung cancer surgery and associated with a morbidity and mortality Postoperative lymphopenia has been recently identified as one of risk factors for postoperative pneumonia According to recent studies in polytrauma cancer or septic shock T cells dysfunction may be related to high expression of inhibitory receptors on lymphocytes
Detailed Description:
This study will investigate prospectively TIM-3 PD-1 and CTLA4 expression on lymphocytes T cells before and after lung cancer surgery Patients 18 years with no history of immunosuppressive state will be included
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2017-A03391-52 | OTHER | ID-RCB | None |